Mibefradil,
Mibefradil Dihydrochloride,
Posicor,
Ro 40 5967,
Ro 40-5967,
Ro 405967,
Mibefradil dihydrochloride,
116666-63-8,
Posicor,
Mibefradil (dihydrochloride),
MIBEFRADIL 2HCL,
Ro 40-5967,
UNII-842TUP3PQ8,
Mibefradil HCl,
Mibefradil hydrochloride,
Mibefradil dihydrochloride [USAN],
842TUP3PQ8,
RO 40-5967/001,
NCGC00094089-01,
DSSTox_CID_24204,
DSSTox_RID_80117,
DSSTox_GSID_44204,
(1S,2S)-(2-((3-(2-Benzimidazolyl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate, dihydrochloride,
Mibefradil dihydrochloride (USAN),
Acetic acid, methoxy-, 2-(2-((3-(1H-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, dihydrochloride, (1S-cis)-,
CAS-116666-63-8,
Ro-405967-001,
C29H38FN3O3.2ClH,
Posicor (TN),
Cerate 50,
AC1L1TOB,
AC1Q3ALR,
Mibefradil-dihydrochloride,
SCHEMBL120810,
C29H38FN3O3.2HCl,
CHEMBL1534525,
DTXSID8044204,
MTJLQTFHJIHXIX-GDUXWEAWSA-N,
AOB31771,
BCP15607,
EX-A2252,
Tox21_111244,
Tox21_500748,
3848AH,
FD5011,
HY-15553A,
MFCD00881804,
AKOS017343957,
Tox21_111244_1,
CCG-222052,
CS-1189,
LP00748,
SB17509,
VA11293,
NCGC00161420-06,
NCGC00261433-01,
Ro-40-5967,
BC238043,
LS-12466,
Mibefradil dihydrochloride; Ro 40-5967,
EU-0100748,
FT-0631084,
Ro-40-5967/001,
D05024,
M 5441,
C-23246,
SR-01000075997,
J-003469,
SR-01000075997-1,
(1s,2s)-(2-((3-(2-benzimidazolyl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride,
(1S,2S)-2-(2-((3-(1H-benzo[d]imidazol-2-yl)propyl)(methyl)amino)ethyl)-6-fluoro-1-isopropyl-1,2,3,4-tetrahydronaphthalen-2-yl 2-methoxyacetate dihydrochloride,
(1S,2S)-2-(2-{[3-(1H-1,3-benzodiazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-(propan-2-yl)-1,2,3,4-tetrahydronaphthalen-2-yl 2-methoxyacetate dihydrochloride,
(1S,2S)-2-[2-[[3-(1H-Benzimidazol-2yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl methoxyacetoacetate dihydrochloride,
[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methyl-amino]ethyl]-6-fluoro-1-isopropyl-tetralin-2-yl] 2-methoxyacetate dihydrochloride,
[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate dihydrochloride,
Acetic acid, 2-methoxy-, (1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, hydrochloride (1:2),
Acetic acid, methyl-, 2-(2-((3-(1H-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, dihydrochloride, (1S-cis)-,
Acetic acid,2-methoxy-,(1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenylester, hydrochloride (1:2),
Ro 40-5967; (1S,2S)-2-[2[[3-(2-benzimidazolylpropyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride,
Mibefradil,
CID60662,
C29-H38-F-N3-O3.2Cl-H,
(1S,2S)-2-[2[[3-(2-Benzimidazolylpropyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate hydrate dihydrochloride,
116644-53-2,